New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on October 28, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Significant shareholders of Bio Green Med Solution, Kim Choy Yap and Yee Lung Ong, have recently sold substantial portions of their stock holdings. Kim Choy Yap sold 19,595 shares, amounting to $37,230, while Yee Lung Ong sold 19,858 shares, totaling $39,517.
Recent Updates on BGMS stock
Bio Green Med Solution (BGMS) has recently finalized an Asset Purchase Agreement with Tethra Biosciences Inc., selling certain assets including patent rights related to Plogosertib for $300,000, with a potential milestone payment of $170,000. This transaction signifies a strategic shift in the company’s operations, potentially affecting its market position by transferring key intellectual property. Additionally, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these developments, Spark, TipRanks’ AI Analyst, rates BGMS as Underperform due to the company’s financial strain, operational inefficiencies, and unattractive valuation metrics such as a negative P/E ratio and lack of dividend yield, resulting in a low overall stock score.
Spark’s Take on BGMS Stock
According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.
Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on BGMS stock, click here.
More about Bio Green Med Solution
YTD Price Performance: -97.84%
Average Trading Volume: 343,356
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.12M